Showcasing Lotte Biologics ToolBox Approach for Bispecific Antibody Purification & ADC Conjugation Modalities - 17th World ADC San Diego

Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Showcasing Lotte Biologics ToolBox Approach for Bispecific Antibody Purification & ADC Conjugation Modalities

3:00 pm - Monday 12th October 2026

Highlighting capabilities of Lotte Biologics single use facility
Breaking down Lotte’s ToolBox approach for bispecific antibody purification and bispecific antibody ADC conjugation development
Signifying the importance of mixing in ADC scale up and utilization of CFD modelling

Speakers:

Revathi Masilamani

Revathi Masilamani

Senior Manager

Lotte Biologics